Larry W. Hawk mostly deals with Bupropion, Developmental psychology, Internal medicine, Randomized controlled trial and Psychiatry. His studies in Bupropion integrate themes in fields like Dopaminergic, Dopamine receptor D2, Dopamine transporter and Dopamine. His Developmental psychology study combines topics in areas such as Substance abuse, Moro reflex, Audiology and Fear-potentiated startle.
He works mostly in the field of Internal medicine, limiting it down to topics relating to Anesthesia and, in certain cases, Cotinine. The study incorporates disciplines such as Catecholamine and Norepinephrine in addition to Psychiatry. His study in the field of Methylphenidate also crosses realms of Discounting.
Larry W. Hawk spends much of his time researching Developmental psychology, Psychiatry, Clinical psychology, Internal medicine and Abstinence. His Developmental psychology research is multidisciplinary, incorporating perspectives in Audiology, Methylphenidate, Attention deficit hyperactivity disorder, Cognition and Reinforcement. His study in Psychiatry focuses on Disinhibition in particular.
His research on Internal medicine frequently links to adjacent areas such as Bupropion. His Abstinence study incorporates themes from Psychological intervention, Nicotine replacement therapy and Varenicline. His Nicotine research incorporates elements of Sex characteristics and Pharmacology.
His primary scientific interests are in Nicotine, Varenicline, Craving, Cognition and Clinical trial. His Nicotine study results in a more complete grasp of Internal medicine. His work carried out in the field of Varenicline brings together such families of science as Randomized controlled trial and Abstinence.
His Craving course of study focuses on Nicotine withdrawal and Clinical psychology, Subsequent Relapse, Nicotine replacement therapy and Affect. His research in Cognition intersects with topics in Cognitive psychology, Methylphenidate and Stimulant. His study on Juvenile delinquency is often connected to Human factors and ergonomics, Suicide prevention and Injury prevention as part of broader study in Developmental psychology.
Larry W. Hawk mainly focuses on Clinical psychology, Developmental psychology, Context, Cognition and Nicotine. His work deals with themes such as Varenicline, Subsequent Relapse, Nicotine withdrawal, Abstinence and Nicotine replacement therapy, which intersect with Clinical psychology. His Developmental psychology research includes elements of Longitudinal study and Temperament.
Context combines with fields such as Craving, Growth model, Latent variable, Early adolescence and Moderation in his investigation. His Cognition research is multidisciplinary, incorporating elements of Variety, Sample, Sensation seeking and Stimulant. His work on Cotinine as part of general Nicotine research is frequently linked to Pharmacogenetics, CYP2A6, Chromosome 19 and Genome-wide association study, thereby connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Affective individual differences and startle reflex modulation.
Edwin W. Cook;Larry W. Hawk;Tammy L. Davis;Victor E. Stevenson.
Journal of Abnormal Psychology (1991)
Reaction Time Variability in ADHD: A Review
Leanne Tamm;Megan E. Narad;Tanya N. Antonini;Kathleen M. O’Brien.
Neurotherapeutics (2012)
Role of Functional Genetic Variation in the Dopamine D2 Receptor ( DRD2 ) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials
Caryn Lerman;Christopher Jepson;E. Paul Wileyto;Leonard H. Epstein.
Neuropsychopharmacology (2006)
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial
Caryn Lerman;Robert A. Schnoll;Larry W. Hawk;Paul M Cinciripini.
The Lancet Respiratory Medicine (2015)
Fearfulness and Startle Potentiation during Aversive Visual Stimuli
Edwin W. Cook;Tammy L. Davis;Larry W. Hawk;Ellen L. Spence.
Psychophysiology (2007)
Self-regulation in ADHD: The role of error processing
Keri Shiels;Larry W. Hawk.
Clinical Psychology Review (2010)
Pharmacogenetic investigation of smoking cessation treatment.
Caryn Lerman;Peter G Shields;E Paul Wileyto;Janet Audrain.
Pharmacogenetics (2002)
Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception
Andrea S Licht;Jill M Murphy;Andrew J Hyland;Brian V Fix.
Sexually Transmitted Infections (2010)
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
F Patterson;RA Schnoll;EP Wileyto;A Pinto.
Clinical Pharmacology & Therapeutics (2008)
Mediating mechanisms for the impact of bupropion in smoking cessation treatment.
Caryn Lerman;David Roth;Vyga Kaufmann;Janet Audrain.
Drug and Alcohol Dependence (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Southern California
State University of New York
Centre for Addiction and Mental Health
University at Buffalo, State University of New York
Centre for Addiction and Mental Health
Florida International University
University of Washington
State University of New York
Buffalo State College
New York University
Deakin University
Intel (United States)
University of Miami
National University of Cuyo
Tel Aviv University
Kyushu University
Hanyang University
Pacific Northwest National Laboratory
Paw Print Genetics
University of Oxford
National Center for Agricultural Utilization Research
University of Essex
University of Pau and the Adour Region
University of Colorado Boulder
University of California, Berkeley
Bocconi University